NCT01589757

Brief Summary

MAIN STUDY: Low glycaemic index (GI) diets are recommended by the Canadian Diabetes Association for treating type 1 and 2 diabetes mellitus (DM), but the role of GI in the management of gestational diabetes(GDM)is not yet clear. The main purpose of this study is to determine the effect of a low GI diet on blood sugar control in women with GDM. The effect of a low GI diet on maternal oxidative stress, pregnancy and delivery outcomes and markers of risk for diabetes after birth in both the mother and baby will also be assessed. SUB-STUDY: The main purpose of the sub-study is to determine if the breast milk (BM) of women with GDM consuming a low GI diet will have a higher antioxidant capacity than the BM of women receiving a medium-high GI diet (control/standard care). The effect of a low glycaemic index diet on maternal dietary intake of specific nutrient-antioxidants (i.e. vitamin C, E, and beta-carotene) (prenatal and postpartum) and concentration of vitamin C, E, and beta-carotene in participants' transitional and mature BM will also be assessed. The ORAC (Oxygen radical absorbance capacity) assay will be used to assess overall antioxidant capacity. The antioxidant capacity of BM in women with GDM will also be compared with that of women without GDM. Hypotheses: MAIN: The use of low-GI foods in the management of GDM reduces postprandial BG and oxidative stress; thereby reducing maternal and infant perinatal complications. SUB-STUDY: Breast milk (BM) of women with GDM consuming a low GI diet will have higher BM antioxidant than women receiving the medium to high GI diet. BM of women with GDM will have lower antioxidant capacity than that of women without GDM.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
99

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Oct 2011

Typical duration for phase_2

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2011

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

April 19, 2012

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 2, 2012

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
Last Updated

May 20, 2016

Status Verified

May 1, 2016

Enrollment Period

3.9 years

First QC Date

April 19, 2012

Last Update Submit

May 19, 2016

Conditions

Keywords

"glycaemic index""glycemic index"hyperglycaemiahyperglycemiapregnancy"dietary intervention""education evaluation"antioxidant"Impaired Glucose Tolerance of Pregnancy""Gestational Diabetes Mellitus""Breast Milk"

Outcome Measures

Primary Outcomes (2)

  • MAIN STUDY: Percentage of postprandial self monitored blood glucose (SMBG) values within the target range

    SMBG values are obtained 4 times daily (1 fasting and 3 postprandial) throughout the study from the randomization to delivery. The endpoint is a single value for each participant - namely the percentage of all the postprandial SMBG values within the target range recommended by the Canadian Diabetes Association (5.0 to 6.6 mmol/L)

    From randomization to delivery

  • SUB-STUDY (n=75): Oxygen Radical Absorbance Capacity (ORAC) (Antioxidant Capacity) of transitional and mature breast milk.

    Breast milk samples (25 mL) will be collected 1 week and 8 weeks after birth from a complete breast milk collection. Measures will be compared between and within groups.

    1 week and 8 weeks postpartum

Secondary Outcomes (51)

  • MAIN STUDY: Infant birth weight

    At delivery

  • MAIN STUDY: Percentage of self-monitored fasting glucose values within the target range

    From randomization to delivery

  • MAIN STUDY: Glucose variability

    From randomization to delivery

  • MAIN STUDY: Insulin prescription incidence

    From randomization to delivery

  • MAIN STUDY: Mean fasting glucose

    From randomization to delivery

  • +46 more secondary outcomes

Study Arms (2)

Standard Care

PLACEBO COMPARATOR

Standard care dietary advice to emphasize high fiber foods with a moderate to high GI

Other: Low GI diet

Low GI Diet

EXPERIMENTAL

Low GI dietary advice in addition to standard care

Other: Standard Care

Interventions

Standard dietary advice for women with GDM with special emphasis on use of high fiber or whole grain carbohydrate foods with a medium to high GI. What's on Your Plate? and 3-dimensional food models will be used to teach servings size and meal planning. This groups will be provided with food substitution lists (key-foods method) composed of medium to high GI foods.

Also known as: medium to high Glycaemic Index
Low GI Diet

Nutrition education according to standard care similar to the control group with supplementary GI-education. GI-education will be taught using the "Stop-Light-Method". This groups will be provided with food substitution lists (key-foods method) composed of low-GI carbohydrate-containing food. The GI-education tool(s) will build on standard care education where patients are taught which food groups contain carbohydrate.

Also known as: glycemic index, glycaemic index, low glycemic carbohydrates, low glycaemic carbohydrates
Standard Care

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women:
  • ≥ 18 years of age
  • diagnosed with gestational diabetes mellitus (GDM) or impaired glucose tolerance of pregnancy (IGTP) according to Canadian Diabetes Association (CDA) criteria
  • being followed within DIP (one of 4 sites)
  • willing and able to give informed consent
  • willing and able to comply with the study protocol

You may not qualify if:

  • Women:
  • with acute or chronic illness other than GDM or IGTP or use of drug (other than insulin) which may affect carbohydrate metabolism, gastrointestinal function or carbohydrate digestion (i.e. crohn's disease, HIV/AIDS, liver disease, kidney disease etc.).
  • known to have type 1 or type 2 DM prior to pregnancy
  • known multi-fetal pregnancy at enrolment
  • ≥ 33 weeks' gestation
  • prescribed oral anti-hyperglycaemic medication
  • insurmountable language barriers
  • SUB-STUDY control group (women without GDM) Same as for Main study except absence of GDM

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

MAIN STUDY ONLY: St Joseph's Heathcare Hamilton, 50 Charlton Avenue East

Hamilton, Ontario, L8N 4A6, Canada

Location

St. Michael's Hospital

Toronto, Ontario, M5B 1W8, Canada

Location

Mt Sinai Hospital

Toronto, Ontario, M5G 1X5, Canada

Location

Sunnybrook Health Sciences Centre

Toronto, Ontario, Room H145, 2075 Bayview Avenue, Canada

Location

Related Publications (7)

  • Ceriello A. Acute hyperglycaemia and oxidative stress generation. Diabet Med. 1997 Aug;14 Suppl 3:S45-9. doi: 10.1002/(sici)1096-9136(199708)14:3+3.3.co;2-i.

    PMID: 9272613BACKGROUND
  • Ceriello A. The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications. Diabet Med. 1998 Mar;15(3):188-93. doi: 10.1002/(SICI)1096-9136(199803)15:33.0.CO;2-V. No abstract available.

    PMID: 9545118BACKGROUND
  • Huang D, Ou B, Prior RL. The chemistry behind antioxidant capacity assays. J Agric Food Chem. 2005 Mar 23;53(6):1841-56. doi: 10.1021/jf030723c.

    PMID: 15769103BACKGROUND
  • Saenz AT, Elisia I, Innis SM, Friel JK, and Kitts DD. Use of ORAC to assess antioxidant capacity of human milk. Journal of Food Composition and Analysis 22:694-698, 2009

    BACKGROUND
  • Elisia I, Kitts DD. Quantification of hexanal as an index of lipid oxidation in human milk and association with antioxidant components. J Clin Biochem Nutr. 2011 Nov;49(3):147-52. doi: 10.3164/jcbn.10-142. Epub 2011 Sep 3.

    PMID: 22128211BACKGROUND
  • Wolever, TMS. The Glycaemic Index: A Physiological Classification of Dietary Carbohydrate. Ontario, Canada: CABI, 2006.

    BACKGROUND
  • Grant SM, Wolever TMS. Perceived barriers to application of glycaemic index: valid concerns or lost in translation? Nutrients. 2011 Mar;3(3):330-340. doi: 10.3390/nu3030330. Epub 2011 Feb 28.

    PMID: 22254100BACKGROUND

MeSH Terms

Conditions

Diabetes, GestationalHyperglycemia

Interventions

Standard of CareGlycemic Index

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and EvaluationNutritive ValueNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaFood QualityFood TechnologyFood IndustryIndustryTechnology, Industry, and AgriculturePublic HealthEnvironment and Public Health

Study Officials

  • Thomas MS Wolever, MD, PhD

    University of Toronto/ St Michael's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 19, 2012

First Posted

May 2, 2012

Study Start

October 1, 2011

Primary Completion

September 1, 2015

Study Completion

September 1, 2015

Last Updated

May 20, 2016

Record last verified: 2016-05

Locations